BR0011919A - Agonistas de somatostatina - Google Patents
Agonistas de somatostatinaInfo
- Publication number
- BR0011919A BR0011919A BR0011919-9A BR0011919A BR0011919A BR 0011919 A BR0011919 A BR 0011919A BR 0011919 A BR0011919 A BR 0011919A BR 0011919 A BR0011919 A BR 0011919A
- Authority
- BR
- Brazil
- Prior art keywords
- trp
- cys
- alkyl
- group
- tyr
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14102899P | 1999-06-25 | 1999-06-25 | |
PCT/US2000/017401 WO2001000676A1 (en) | 1999-06-25 | 2000-06-23 | Somatostatin agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0011919A true BR0011919A (pt) | 2002-03-19 |
Family
ID=22493842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0011919-9A BR0011919A (pt) | 1999-06-25 | 2000-06-23 | Agonistas de somatostatina |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1189942A1 (es) |
JP (1) | JP4041311B2 (es) |
CN (1) | CN1367792A (es) |
AR (1) | AR024463A1 (es) |
AU (1) | AU770958B2 (es) |
BR (1) | BR0011919A (es) |
CA (1) | CA2377265A1 (es) |
CZ (1) | CZ20014534A3 (es) |
HU (1) | HUP0201696A3 (es) |
IL (1) | IL146941A0 (es) |
MX (1) | MXPA01013127A (es) |
PL (1) | PL352763A1 (es) |
RU (1) | RU2263677C2 (es) |
WO (1) | WO2001000676A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60220157T2 (de) | 2001-03-06 | 2008-01-17 | Il Consorzio Ferrara Richerche | Verfahren zur modulierung der proliferation von medullären schilddrüsen-karzinomzellen |
WO2003057214A1 (en) | 2001-12-28 | 2003-07-17 | Somatocor Pharmaceuticals, Inc. | Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands |
US8470770B2 (en) | 2007-04-30 | 2013-06-25 | Technion Research & Development Foundation Ltd. | Antimicrobial agents |
EP2142257A2 (en) * | 2007-04-30 | 2010-01-13 | Technion Research & Development Foundation Ltd. | Anticancerous polymeric agents |
MX2012005862A (es) * | 2009-11-23 | 2012-09-07 | Palatin Technologies Inc | Peptidos ciclicos especificos del receptor de melanocortina-1. |
WO2011151782A1 (en) | 2010-06-02 | 2011-12-08 | Preglem Sa | A role for somatostatin to modulate initiation of follicular growth in the human ovary |
WO2013119800A1 (en) | 2012-02-07 | 2013-08-15 | Massachusetts Institute Of Technology | Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness |
US9724396B2 (en) | 2013-03-15 | 2017-08-08 | Massachusetts Institute Of Technology | Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness |
US10317418B2 (en) | 2015-02-24 | 2019-06-11 | Massachusetts Institute Of Technology | Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3264693D1 (en) * | 1981-12-24 | 1985-08-14 | Ciba Geigy Ag | Cyclic octapeptides and pharmaceutical compositions thereof, and processes for their production and use |
HU207104B (en) * | 1991-01-25 | 1993-03-01 | Biosignal Kutato Fejlesztoe Kf | Process for producing new somatostatin analogs inhibiting tumour growth and pharmaceutical compositions comprising such compounds |
RO117259B1 (ro) * | 1993-08-09 | 2001-12-28 | Biomeasure Inc. | Derivaţi peptidici, terapeutici |
PL334089A1 (en) * | 1996-12-04 | 2000-01-31 | Sod Conseils Rech Applic | Compounds antagonistic in respect to somatostatin |
DE69812084T2 (de) * | 1997-05-01 | 2003-12-24 | Cedars-Sinai Medical Center, Los Angeles | Verfahren zur behandlung von hyperprolaktinämia und prolaktinomen |
AU8019898A (en) * | 1997-05-13 | 1998-12-08 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome |
CA2290592A1 (en) * | 1997-05-13 | 1998-11-19 | Michael Anthony Cawthorne | Somatostatin and somatostatin agonists for decreasing body weight |
WO1998051330A1 (en) * | 1997-05-13 | 1998-11-19 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) | Method and compositions for treating hyperlipidemia and other conditions |
-
2000
- 2000-06-23 CA CA002377265A patent/CA2377265A1/en not_active Abandoned
- 2000-06-23 CN CN00811189A patent/CN1367792A/zh active Pending
- 2000-06-23 HU HU0201696A patent/HUP0201696A3/hu unknown
- 2000-06-23 PL PL00352763A patent/PL352763A1/xx not_active Application Discontinuation
- 2000-06-23 AR ARP000103155A patent/AR024463A1/es unknown
- 2000-06-23 BR BR0011919-9A patent/BR0011919A/pt not_active Application Discontinuation
- 2000-06-23 JP JP2001506685A patent/JP4041311B2/ja not_active Expired - Fee Related
- 2000-06-23 CZ CZ20014534A patent/CZ20014534A3/cs unknown
- 2000-06-23 MX MXPA01013127A patent/MXPA01013127A/es unknown
- 2000-06-23 IL IL14694100A patent/IL146941A0/xx unknown
- 2000-06-23 WO PCT/US2000/017401 patent/WO2001000676A1/en active IP Right Grant
- 2000-06-23 RU RU2002101732/04A patent/RU2263677C2/ru not_active IP Right Cessation
- 2000-06-23 EP EP00948520A patent/EP1189942A1/en not_active Ceased
- 2000-06-23 AU AU62000/00A patent/AU770958B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
MXPA01013127A (es) | 2002-11-04 |
PL352763A1 (en) | 2003-09-08 |
EP1189942A1 (en) | 2002-03-27 |
CN1367792A (zh) | 2002-09-04 |
JP4041311B2 (ja) | 2008-01-30 |
HUP0201696A2 (en) | 2002-09-28 |
AR024463A1 (es) | 2002-10-02 |
WO2001000676A1 (en) | 2001-01-04 |
HUP0201696A3 (en) | 2002-10-28 |
JP2003503369A (ja) | 2003-01-28 |
CA2377265A1 (en) | 2001-01-04 |
AU770958B2 (en) | 2004-03-11 |
AU6200000A (en) | 2001-01-31 |
CZ20014534A3 (cs) | 2002-06-12 |
IL146941A0 (en) | 2002-08-14 |
RU2263677C2 (ru) | 2005-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20040775A1 (es) | DERIVADOS DE INDOL COMO AGONISTAS DE ADRENORECEPTORES ß2 | |
BR0011919A (pt) | Agonistas de somatostatina | |
BR0307429A (pt) | Composto, uso do mesmo, composição farmacêutica, e, método para o tratamento de distúrbios ou doenças relacionadas com receptor de histamina h3 | |
BR0306150A (pt) | Composto, uso de um composto, e, composição farmacêutica | |
BRPI0615307A2 (pt) | agonistas de adrenorreceptor alfa2c | |
BR9813973A (pt) | Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo para o tratamento de um paciente sofrendo de uma condição. | |
BR9813976A (pt) | Composto, composição farmacêutica, uso de um composto, processos para o tratamento de um paciente, e, para a preparação de um composto. | |
PE20080013A1 (es) | Derivados de amina como agentes moduladores de receptores adrenergicos y muscarinicos | |
PE20050420A1 (es) | Fenacilo 2-hidroxi-3-diaminoalcanos | |
PE20051136A1 (es) | Derivados de sulfonamida | |
BRPI0203172B8 (pt) | composição farmacêutica para acondroplasia | |
BRPI0412761A (pt) | inibidores de serino proteases, particularmente a protease ns3-ns4a do vhc | |
BRPI0516105A (pt) | composições de fator de crescimento derivado de plaqueta e métodos de uso destas | |
PE20050142A1 (es) | 2-hidroxi-3-diaminoalcanos de benzamida | |
BRPI0715579A2 (pt) | "composto, composição farmacêutica e uso de um composto" | |
BR9813989A (pt) | Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo para o tratamento de um paciente sofrendo de uma condição | |
SV2008002986A (es) | Moduladores de indol sulfonamida de receptores de progesterona ref. x-17207 | |
BR0010348A (pt) | Uso de antagonistas seletivos de receptor <244>~ 1b~-adrenérgico para aperfeiçoamento de disfunção sexual | |
BRPI0613664A8 (pt) | antagonista de 3-lactamil fenilalanina,cisteína e serina vasopressina | |
CA2060034A1 (en) | Tumour growth-inhibiting somatostatin analogues, pharmaceutical compositions containing them and process for preparing same | |
BR0206595A (pt) | Composto, composição farmacêutica, e uso de um composto | |
MA30511B1 (fr) | Polymorphes de n-hydroxy -3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2- propenamide | |
BRPI0510221A (pt) | composto de aril cetona, composição, forma de dosagem unitária, uso da composição e método para preparar uma composição | |
BR9812088A (pt) | Combinação de componentes, uso desta, processos para a preparação da mesma, para o tratamento de distúrbios afetivos, para o tratamento de depressão, e para melhorar o inìcio de ação terapêutica, formulação farmacêutica, e, kit | |
BR0008509A (pt) | Composição farmacêutica oral estabilizada contendo iodeto e iodato e método |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |